Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,457 public trials 1,141 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Active, Not Recruiting

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

NCT04541212

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Centre Hospitalier de l'université de Montréal (CHUM) Montreal, Quebec, Canada
  • CIUSSS Ouest de l'ile de Montreal - St-Mary's Hospital Montreal, Quebec, Canada
  • CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • CIUSSS du Centre-Ouest de l'Île de Montréal - Jewish General Hospital Montreal, Quebec, Canada
View Trial Details
Active, Not Recruiting

Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer

NCT02788981

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • University of Alabama - Birmingham Birmingham, Alabama, United States
  • University of Chicago Chicago, Illinois, United States
  • Northshore University HealthSystem Evanston, Illinois, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

NCT02804815

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +29 more
Locations
  • Bon Secours Hospital Cork, Ireland
  • Cork University Hospital Cork, Ireland
  • Beaumont Hospital Dublin, Ireland
  • Mater Misericordiae University Hospital Dublin, Ireland
View all 82 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer

NCT05346224

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • the First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • The first affiliated hospital of Anhui Medical University Hefei, Anhui, China
  • The first affiliated hospital of USTC (Anhui Provincial Hospital) Hefei, Anhui, China
View all 79 locations
View Trial Details

Related conditions